The overall objective of IntoValue is to analyze the extent of how institutions contribute to increasing value and reducing waste in biomedical research. **Results article:** Wieschowski, S., Riedel, N., Wollmann, K., Kahrass, H., Müller-Ohlraun, S., Schürmann, C., Kelley, S., Kszuk, U., Siegerink, B., Dirnagl, U., Meerpohl, J., & Strech, D. (2019). Result dissemination from clinical trials conducted at German university medical centers was delayed and incomplete. Journal of Clinical Epidemiology, 115, 37–45. https://doi.org/10.1016/j.jclinepi.2019.06.002 **Dataset**: Riedel, Nico, Wieschowski, Susanne, Bruckner, Till, Holst, Martin R., Kahrass, Hannes, Nury, Edris, Meerpohl, Joerg J., Salholz-Hillel, Maia, & Strech, Daniel. (2021). Dataset for the IntoValue 1 + 2 studies on results dissemination from clinical trials conducted at German university medical centers completed between 2009 and 2017 (Version 2) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.7633995